A poor response to the COVID-19 vaccination has been observed in patients with CLL and WM receiving BTK inhibitors, although as many as half of patients with CLL and WM who were treatment-naive also lacked serological response to vaccination (38, 39). The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.